New Delhi, March 21 -- American drugmaker Eli Lilly and Company launched its weight-loss injectable drug Mounjaro in India on Thursday, becoming the first multinational pharma firm to bring a treatment already widely used in Western markets to India, where obesity and associated type-2 diabetes poses a major health burden....